Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01944332 · ClinicalTrials.gov registry record · NA

Gamete Treatment to Correct Fertilization Failure

A NA study of Infertility, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
1,200
Enrollment target
1
Study location

NCT01944332: Recruiting NA study of Infertility, sponsored by Weill Medical College of Cornell University.

NCT01944332 is a NA study of Infertility that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 1,200 participants, below the 7,573-participant average among 74 other Infertility trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01944332, a NA study of Infertility, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
1,200 participants
Enrollment target
1
Study location

Study Summary

In this proposed research study, the investigators plan to assess the efficacy of gametes' (egg and sperm) treatment on fertilization as well as pre- and post-implantation embryo development.

Primary Outcome

Efficacy of gamete treatment on fertilization

Conditions Studied

Interventions

  • PROCEDURE gamete treatment

Study Locations (1)

New York

  • Center fo Reproductive Medicine - New York

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2007-09
Est. Completion 2027-11-30
Phase NA

What NCT01944332 shows while recruiting

NCT01944332 is an interventional study that assigns participants to a tested intervention. Its 1,200 participants enrollment target places it among the larger protocols in the corpus, below the 7,573-participant average among 74 other Infertility trials with a reported enrollment target (84% lower).

The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 1 intervention - of which gamete treatment is the first listed.

NCT01944332 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01944332 about?

NCT01944332 is a clinical study titled "Gamete Treatment to Correct Fertilization Failure". In this proposed research study, the investigators plan to assess the efficacy of gametes' (egg and sperm) treatment on fertilization as well as pre- and post-implantation embryo development.

What is the current status of trial NCT01944332?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,200 participants. The study started on 2007-09. Estimated completion is 2027-11-30.

What conditions does trial NCT01944332 study?

This clinical trial studies the following conditions: Infertility.

What interventions are being tested in trial NCT01944332?

The interventions under investigation include: gamete treatment (PROCEDURE).

Who is sponsoring clinical trial NCT01944332?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01944332 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01944332's enrollment target sits among peer trials

1,200 16th of 74 higher than 59 of 74 other Infertility trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001987 · 1,200 participants

    Genetic Studies of Insulin and Diabetes

  • NCT00477100 · 1,200 participants

    Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer

  • NCT01209000 · 1,200 participants

    Nephrotic Syndrome Study Network

  • NCT02861573 · 1,200 participants · Phase 1

    Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01944332, the US trial registry maintained by the National Library of Medicine. NCT01944332 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.